Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Clinical outcomes in patients with unintended pregnancy after liver transplantation: A multicenter registry cohort study.
Analysis of treatment benefits and prognostic factors for Post-Transplant hepatocellular carcinoma recurrence in a large Euro-American-Asian cohort.
The liver frailty index enhances mortality risk prediction above and beyond MELD 3.0 alone.
Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among decompensated cirrhosis patients.
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.
Clinically relevant cut-points for changes in the Liver Frailty Index are associated with waitlist mortality in patients with cirrhosis.
Performance of race-neutral eGFR equations in patients with decompensated cirrhosis.
Role of biomarkers in the diagnosis and management of HCC.
Barriers to liver transplant referral in safety net settings: A national provider survey.
Controversies in terlipressin and transplantation in the United States: How do we MELD the two?